Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Mar 21, 2023

BUY
$1.58 - $2.82 $632 - $1,128
400 New
400 $1.03 Million
Q4 2021

Mar 21, 2023

BUY
$2.06 - $3.61 $824 - $1,444
400 New
400 $836,000
Q3 2021

Mar 22, 2023

BUY
$2.98 - $4.31 $1,192 - $1,723
400 New
400 $1.19 Million
Q2 2021

Mar 22, 2023

BUY
$3.08 - $5.13 $1,232 - $2,052
400 New
400 $1.6 Million

Others Institutions Holding AXLA

About Axcella Health Inc.


  • Ticker AXLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,500,896
  • Description
  • Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...
More about AXLA
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.